Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1188320130070050576
Gut and Liver
2013 Volume.7 No. 5 p.576 ~ p.584
What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study
Yusuke Kawamura

Kenji Ikeda
Taito Fukushima
Yuya Seko
Tasuku Hara
Hitomi Sezaki
Tetsuya Hosaka
Norio Akuta
Masahiro Kobayashi
Satoshi Saitoh
Fumitaka Suzuki
Yoshiyuki Suzuki
Yasuji Arase
Hiromitsu Kumada
Abstract
Background/Aims:The aim of this study was to determine the pharmacodynamics of cisplatin following three different treatment procedures for intrahepatic arterial infusion therapy for hepatocellular carcinoma (HCC).

Methods:We divided 13 HCC patients into the following three groups: group A, lone injection of cisplatin (n=3); group B, combined injection of cisplatin and lipiodol, with embolization using small gelatin cubes (GCs) (n=5); and group C, injection of suspended lipiodol with cisplatin powder, with embolization using small GCs (n=5). In each group, the free cisplatin concentration in the hepatic vein was measured at 0, 5, 10, and 30 minutes.

Results:The mean free cisplatin concentrations were as follows. For group A, the mean was 48.58 ¥ìg/mL at 0 minute, 7.31 ¥ìg/mL at 5 minutes, 5.70 ¥ìg/mL at 10 minutes, and 7.15 ¥ìg/mL at 30 minutes. For the same time points, for group B, the concentrations were 8.66, 4.23, 3.22, and 1.65 ¥ìg/mL, respectively, and for group C, the concentrations were 4.81, 2.61, 2.52, and 1.75 ¥ìg/mL, respectively. The mean area under the curve (AUC)0-infinity for the free cisplatin concentration was 7.80 in group A, 2.48 in group B, and 2.27 in group C. The AUC0-infinity for the free cisplatin concentration gradually decreased, from group A to group C.

Conclusions:These results indicate that the combination of lipiodol and small GCs may be useful for delaying cisplatin drainage from the liver.
KEYWORD
Cisplatin, Attention, Carcinoma, hepatocellular, Drug delivery
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed